Tazidime and Oropharyngeal discomfort - a phase IV clinical study of FDA data

Summary:

Oropharyngeal discomfort is reported only by a few people who take Tazidime.

The phase IV clinical study analyzes which people take Tazidime and have Oropharyngeal discomfort. It is created by eHealthMe based on reports of 9,753 people who have side effects while taking Tazidime from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 18, 2023

9,753 people reported to have side effects when taking Tazidime.
Among them, 2 people (0.02%) have Oropharyngeal discomfort.


What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 8,950 Tazidime users for its effectiveness, alternative drugs and more.

What is Oropharyngeal discomfort?

Oropharyngeal discomfort (pain or irritation of oropharynx) is found to be associated with 1,116 drugs and 575 conditions by eHealthMe.

Number of Tazidime and Oropharyngeal discomfort reports submitted per year:

Could Tazidime cause Oropharyngeal discomfort?

Time on Tazidime when people have Oropharyngeal discomfort *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Oropharyngeal discomfort when taking Tazidime *:

  • female: 50 %
  • male: 50 %

Age of people who have Oropharyngeal discomfort when taking Tazidime *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Tazidime *:

  1. Vitamin D2: 1 person, 50.00%
  2. Vancomycin: 1 person, 50.00%
  3. Tobi: 1 person, 50.00%
  4. Symdeko: 1 person, 50.00%
  5. Pulmozyme: 1 person, 50.00%
  6. Piperacillin And Tazobactam: 1 person, 50.00%
  7. Paracetamol: 1 person, 50.00%
  8. Oxycodone: 1 person, 50.00%
  9. Morphine: 1 person, 50.00%
  10. Creon: 1 person, 50.00%

Common side effects people have besides Oropharyngeal discomfort *:

  1. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 50.00%
  2. Tongue Dry: 1 person, 50.00%
  3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 50.00%
  4. Chest Pain: 1 person, 50.00%
  5. Choking Sensation (feeling of obstruction in respiratory system): 1 person, 50.00%
  6. Drug Hypersensitivity: 1 person, 50.00%
  7. Fever: 1 person, 50.00%
  8. Headache (pain in head): 1 person, 50.00%
  9. High Blood Pressure: 1 person, 50.00%
  10. Hyperaemia (increase of blood flow to different tissues in the body): 1 person, 50.00%

Common conditions people have *:

  1. Cystic Fibrosis (disease of the secretary glands): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Oropharyngeal discomfort?

Check whether Oropharyngeal discomfort is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Oropharyngeal discomfort and when was it recovered:

Expand to all the drugs that have ingredients of ceftazidime:

Alternative drugs to, pros and cons of Tazidime:

Common Tazidime side effects:

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oropharyngeal discomfort treatments and more:

COVID vaccines that are related to Oropharyngeal discomfort:

Common drugs associated with Oropharyngeal discomfort:

All the drugs that are associated with Oropharyngeal discomfort:

Common conditions associated with Oropharyngeal discomfort:

All the conditions that are associated with Oropharyngeal discomfort:

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: